These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12404738)

  • 1. [Cost-effectiveness of hip fracture in Japan].
    Ota T; Harada A; Tokuda H
    Nihon Ronen Igakkai Zasshi; 2002 Sep; 39(5):483-8. PubMed ID: 12404738
    [No Abstract]   [Full Text] [Related]  

  • 2. [Absolute risk for fracture and WHO guideline. Economic analysis of pharmacotherapy for osteoporosis].
    Harada A;
    Clin Calcium; 2007 Jul; 17(7):1029-34. PubMed ID: 17607069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost analysis of osteoporotic hip fractures.
    Woratanarat P; Wajanavisit W; Lertbusayanukul C; Loahacharoensombat W; Ongphiphatanakul B
    J Med Assoc Thai; 2005 Oct; 88 Suppl 5():S96-104. PubMed ID: 16869109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden.
    Ström O; Borgstrom F; Zethraeus N; Johnell O; Lidgren L; Ponzer S; Svensson O; Abdon P; Ornstein E; Ceder L; Thorngren KG; Sernbo I; Jonsson B
    Acta Orthop; 2008 Apr; 79(2):269-80. PubMed ID: 18484255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The societal burden of osteoporosis in Sweden.
    Borgström F; Sobocki P; Ström O; Jönsson B
    Bone; 2007 Jun; 40(6):1602-9. PubMed ID: 17433804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of teaching hospitals for the operative management of hip fractures.
    McGuire KJ; Chacko AT; Bernstein J
    Orthopedics; 2011 Oct; 34(10):e598-601. PubMed ID: 21956051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplemental calcium for the prevention of hip fracture: potential health-economic benefits.
    Bendich A; Leader S; Muhuri P
    Clin Ther; 1999 Jun; 21(6):1058-72. PubMed ID: 10440627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hip fractures--an enormous public health problem].
    Thorngren KG
    Lakartidningen; 2006 Oct 4-10; 103(40):2990-2. PubMed ID: 17115667
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacoeconomic analysis of osteoporosis treatment with risedronate.
    Brecht JG; Kruse HP; Felsenberg D; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2003; 23(4):93-105. PubMed ID: 15224498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of outcomes and costs after hip fracture surgery in three hospitals that have different care systems in Japan.
    Kondo A; Zierler BK; Isokawa Y; Hagino H; Ito Y
    Health Policy; 2009 Jul; 91(2):204-10. PubMed ID: 19162364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on direct economic-burden and its risk factors of osteoporotic hip fracture].
    Luo LZ; Xu L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Sep; 26(9):669-72. PubMed ID: 16471214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The national cost of acute care of hip fractures associated with osteoporosis.
    Owen RA; Melton LJ; Gallagher JC; Riggs BL
    Clin Orthop Relat Res; 1980; (150):172-6. PubMed ID: 7428216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women.
    Schousboe JT; Ensrud KE; Nyman JA; Melton LJ; Kane RL
    J Am Geriatr Soc; 2005 Oct; 53(10):1697-704. PubMed ID: 16181168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial.
    Majumdar SR; Lier DA; Beaupre LA; Hanley DA; Maksymowych WP; Juby AG; Bell NR; Morrish DW
    Arch Intern Med; 2009 Jan; 169(1):25-31. PubMed ID: 19139320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic impact of geriatric hip fractures.
    Youm T; Koval KJ; Zuckerman JD
    Am J Orthop (Belle Mead NJ); 1999 Jul; 28(7):423-8. PubMed ID: 10426442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Socioeconomic burden of hip fractures in Germany].
    Weyler EJ; Gandjour A
    Gesundheitswesen; 2007 Nov; 69(11):601-6. PubMed ID: 18080931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and prevention of depression after surgery for hip fracture in older people: cost-effectiveness analysis.
    Romeo R; Knapp M; Banerjee S; Morris J; Baldwin R; Tarrier N; Pendleton N; Horan M; Burns A
    J Affect Disord; 2011 Feb; 128(3):211-9. PubMed ID: 20696480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cost-effectiveness of hip fracture prevention].
    Visentin P; Ciravegna R; Corcelli F; Fabris F
    Epidemiol Prev; 1998; 22(1):44-8. PubMed ID: 9621504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents.
    Singh S; Sun H; Anis AH
    J Rheumatol; 2004 Aug; 31(8):1607-13. PubMed ID: 15290742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.